| Net sales | 1,219.64b | 1,159.06b | 1,136.7b |
| Cost of sales | -429.36b | -389.34b | -366.89b |
| Gross margin | 790.27b | 769.73b | 769.82b |
| Operating expenses | — | — | — |
| Selling, general and administrative | -588.52b | -466.38b | -378.38b |
| Research and development | -99.5b | -96.66b | -92.49b |
| Total operating expenses | -688.02b | -563.04b | -470.87b |
| Operating income | 102.26b | 206.69b | 298.94b |
| Other income (expense) | — | — | — |
| Interest expense | -8.51b | -15.74b | -11.22b |
| Interest income | 3.89b | 3.32b | 3.41b |
| Other non-operating income (expense), net | 0.83b | -8.58b | 47.52b |
| Total other income (expense), net | -3.79b | -21b | 39.72b |
| Earnings before income taxes | 98.46b | 185.69b | 338.66b |
| Income taxes | -25.06b | -17.58b | -53.22b |
| Net earnings | 73.4b | 168.11b | 285.44b |
| Net earnings attributable to noncontrolling interest | 0b | 0b | 0.18b |
| Net earnings attributable to Bio-Techne | 73.4b | 168.11b | 285.26b |